Yat Sun Or,Christopher M. Owens,Bradley B. Brasher,Yao-Ling Qiu,Lijuan Jiang
申请号：
US12851350
公开号：
US09060971B2
申请日:
2010.08.05
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a flaviviridae viral infection, for example, hepatitis C virus (HCV), wherein treatment comprises administering a compound effective to inhibit the function of the HCV NS5A protein and an additional compound or combinations of compounds having anti-HCV activity.
